Clinical predictors of response and remission in inpatients with depressive syndromes

Journal of Affective Disorders

Volumn 133, Issue 1-2, 2011, Pages 137-149

  Riedel, Michael ^a,j   Möller, Hans Jürgen ^a   Obermeier, Michael ^a   Adli, Mazda ^g   Bauer, Michael ^c   Kronmüller, Klaus ^b   Brieger, Peter ^d   Laux, Gerd ^e   Bender, Wolfram ^f   Heuser, Isabella ^g   Zeiler, Joachim ^h   Gaebel, Wolfgang ⁱ   Schennach Wolff, Rebecca ^a   Henkel, Verena ^a   Seemüller, Florian ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^e Inn Salzach Klinikum   (Germany)

^f KLINIKUM MÜNCHEN OST   (Germany)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^h Vivantes Auguste Viktoria Klinikum   (Germany)

ⁱ HEINRICH HEINE UNIVERSITY   (Germany)

^j Vinzenz von Paul Hospital   (Germany)

more..

Author keywords

Inpatients; Major Depression; Predictor; Remission; Response

Indexed keywords

AMITRIPTYLINE; CITALOPRAM; DOXEPIN; MIRTAZAPINE; PAROXETINE; SERTRALINE; TRANYLCYPROMINE; TRIMIPRAMINE; VENLAFAXINE;

ADULT; AGED; ARTICLE; ASSOCIATION; CLINICAL ASSESSMENT; COMORBIDITY; CONTROLLED STUDY; ELECTROCONVULSIVE THERAPY; FEMALE; HAMILTON SCALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MULTICENTER STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POST HOC ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOTHERAPY; REMISSION; SLEEP DEPRIVATION; SUICIDAL IDEATION; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UNIVARIATE ANALYSIS;

ADULT; ANTIDEPRESSIVE AGENTS; COMORBIDITY; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; FEMALE; HOSPITALIZATION; HUMANS; INPATIENTS; MALE; MIDDLE AGED; PROGNOSIS; PSYCHIATRIC STATUS RATING SCALES; REMISSION INDUCTION; SUICIDE, ATTEMPTED; TREATMENT OUTCOME;

EID: 80051665311     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2011.04.007     Document Type: Article

References (49)

1. A. American Psychiatric Practice guideline for the treatment of patients with major depressive disorder (revision) Am. J. Psychiatry 157 2000 1 45
2. R.M. Baron, and D.A. Kenny The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations J. Pers. Soc. Psychol. 51 1986 1173 1182
3. M. Bauer, T. Bschor, A. Pfennig, P.C. Whybrow, J. Angst, M. Versiani, and H.J. Moller World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders in primary care World J. Biol. Psychiatry 8 2007 67 104 (Pubitemid 46690921)
4. P. Cassano, C.N. Soares, L.S. Cohen, A.K. Lyster, and M. Fava Sex- and age-related differences in major depressive disorder with comorbid anxiety treated with fluoxetine Arch Womens Ment Health 7 2004 167 171 (Pubitemid 38981239)
5. Cording, C., Gaebel, W., Spengler, A., 1995. Die neue psychiatrische Basisdokumentation. Eine Empfehlung der DGPPN zur Qualitätssicherung im (teil-) stationären Bereich. Spektrum der Psychiatrie und Nervenheilkunde. [The new psychiatric basic documentation. A recommendation by the DGPPN for quality assurance in inpatient treatment]. Spektrum Psychiatrie Nervenheilkunde, 3-41.
6. J.R. Davidson, E.L. Giller, S. Zisook, and M.J. Helms Predictors of response to monoamine oxidase inhibitors: do they exist? Eur. Arch. Psychiatry Clin. Neurosci. 241 1991 181 186
7. E.Y. Deykin, and A. Dimascio Relationship of patient background characteristics to efficacy of pharmacotherapy in depression J. Nerv. Ment. Dis. 155 1972 209 215
8. G.J. Emslie, T.L. Mayes, R.S. Laptook, and M. Batt Predictors of response to treatment in children and adolescents with mood disorders Psychiatr. Clin. North Am. 26 2003 435 456 (Pubitemid 36583572)
9. M. Fava, A.J. Rush, J.E. Alpert, G.K. Balasubramani, S.R. Wisniewski, C.N. Carmin, M.M. Biggs, S. Zisook, A. Leuchter, R. Howland, D. Warden, and M.H. Trivedi Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report Am. J. Psychiatry 165 2008 342 351 (Pubitemid 351704490)
10. A. Fekadu, S. Wooderson, C. Donaldson, K. Markopoulou, B. Masterson, L. Poon, and A.J. Cleare A multidimensional tool to quantify treatment resistance in depression: the Maudsley staging method J. Clin. Psychiatry 70 2009 177 184
11. C. Friedman, M.S. De Mowbray, and V. Hamilton Imipramine (Tofranil) in depressive states: a controlled trial with inpatients J. Ment. Sci. 107 948-53 1961 948 953
12. F.K. Goodwin Predictors of antidepressant response Bull. Menninger Clin. 57 1993 146 160 (Pubitemid 23148484)
13. M. Hamilton Development of a rating scale for primary depressive illness Br. J. Soc. Clin. Psychol. 6 1967 278 296
14. V. Henkel, F. Seemuller, M. Obermeier, M. Adli, M. Bauer, C. Mundt, P. Brieger, G. Laux, W. Bender, I. Heuser, J. Zeiler, W. Gaebel, A. Mayr, H.J. Moller, and M. Riedel Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression J. Affect. Disord. 115 2009 439 449
15. V. Henkel, F. Seemuller, M. Obermeier, M. Adli, M. Bauer, K. Kronmuller, F. Holsboer, P. Brieger, G. Laux, W. Bender, I. Heuser, J. Zeiler, W. Gaebel, A. Mayr, M. Riedel, and H.J. Moller Relationship between baseline severity of depression and antidepressant treatment outcome Pharmacopsychiatry 44 2011 27 32
16. J.M. Hennings, T. Owashi, E.B. Binder, S. Horstmann, A. Menke, S. Kloiber, T. Dose, B. Wollweber, D. Spieler, T. Messer, R. Lutz, H. Kunzel, T. Bierner, T. Pollmacher, H. Pfister, T. Nickel, A. Sonntag, M. Uhr, M. Ising, F. Holsboer, and S. Lucae Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - findings from the Munich Antidepressant Response Signature (MARS) project J. Psychiatr. Res. 43 2009 215 229
17. R.M. Hirschfeld, J.M. Russell, P.L. Delgado, J. Fawcett, R.A. Friedman, W.M. Harrison, L.M. Koran, I.W. Miller, M.E. Thase, R.H. Howland, M.A. Connolly, and R.J. Miceli Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine J. Clin. Psychiatry 59 1998 669 675 (Pubitemid 29068312)
18. G. Juckel, O. Pogarell, H. Augustin, C. Mulert, F. Muller-Siecheneder, T. Frodl, P. Mavrogiorgou, and U. Hegerl Differential prediction of first clinical response to serotonergic and noradrenergic antidepressants using the loudness dependence of auditory evoked potentials in patients with major depressive disorder J. Clin. Psychiatry 68 2007 1206 1212 (Pubitemid 47395622)
19. N. Khalid, M. Atkins, J. Tredget, M. Giles, K. Champney-Smith, and G. Kirov The effectiveness of electroconvulsive therapy in treatment-resistant depression: a naturalistic study J. ECT 24 2008 141 145
20. N. Kleindienst, R. Engel, and W. Greil Which clinical factors predict response to prophylactic lithium? A systematic review for bipolar disorders Bipolar Disord. 7 2005 404 417 (Pubitemid 41419407)
21. H.C. Kraemer, G.T. Wilson, C.G. Fairburn, and W.S. Agras Mediators and moderators of treatment effects in randomized clinical trials Arch. Gen. Psychiatry 59 2002 877 883
22. D.J. Kupfer, and D.G. Spiker Refractory depression: prediction of non-response by clinical indicators J. Clin. Psychiatry 42 1981 307 312 (Pubitemid 11034012)
23. K. Malhotra, T. Schwartz, and U. Hameed Presence of suicidality as a prognostic indicator J. Postgrad. Med. 50 2004 185 187 (Pubitemid 39440066)
24. H.J. Moller, G. Fischer, and D. Von Zerssen Prediction of therapeutic response in acute treatment with antidepressants. Results of an empirical study involving 159 endogenous depressive inpatients Eur. Arch. Psychiatry Neurol. Sci. 236 1987 349 357
25. M. Myrtek, and F. Foerster The law of initial value: a rare exception Biol. Psychol. 22 1986 227 237 (Pubitemid 16044239)
26. D. O'Leary, F. Costello, N. Gormley, and M. Webb Remission onset and relapse in depression. An 18-month prospective study of course for 100 first admission patients J. Affect. Disord. 57 2000 159 171 (Pubitemid 30119968)
27. S. Pampallona, P. Bollini, G. Tibaldi, B. Kupelnick, and C. Munizza Combined pharmacotherapy and psychological treatment for depression: a systematic review Arch. Gen. Psychiatry 61 2004 714 719 (Pubitemid 38890806)
28. E.S. Paykel Depressive typologies and response to amitriptyline Br. J. Psychiatry 120 1972 147 156
29. E.S. Paykel, B.A. Prusoff, G.L. Klerman, D. Haskell, and A. Dimascio Clinical response to amitriptyline among depressed women J. Nerv. Ment. Dis. 156 1973 149 165
30. H. Pfeiffer, B. Scherer, M. Karg, M. Albus, S. Hecht, S. Scharff-Buessing, and K. Kindermann Week two HAMD score predicts onset of action of TCA Eur. Neuropsychopharmacol. 7 1997 164 165
31. O. Pogarell, G. Juckel, C. Norra, G. Leicht, S. Karch, N. Schaaff, M. Folkerts, A. Ibrahim, C. Mulert, and U. Hegerl Prediction of clinical response to antidepressants in patients with depression: neurophysiology in clinical practice Clin. EEG Neurosci. 38 2007 74 77 (Pubitemid 46866505)
32. B.A. Prusoff, and E.S. Paykel Typological prediction of response to amitriptyline: a replication study Int Pharmacopsychiatry 12 1977 153 159 (Pubitemid 8235015)
33. M. Riedel, H.J. Moller, M. Obermeier, R. Schennach-Wolff, M. Bauer, M. Adli, K. Kronmuller, T. Nickel, P. Brieger, G. Laux, W. Bender, I. Heuser, J. Zeiler, W. Gaebel, and F. Seemuller Response and remission criteria in major depression-a validation of current practice J. Psychiatr. Res. 44 2010 1063 1068
34. A.A. Robin, and G.E. Langley A controlled trial of imipramine Br. J. Psychiatry 110 419-22 1964 419 422
35. H. Sauer, H. Kick, H.W. Minne, and B. Schneider Prediction of the amitriptyline response: psychopathology versus neuroendocrinology Int Clin Psychopharmacol 1 1986 284 295
36. F. Seemuller, M. Riedel, M. Obermeier, M. Bauer, M. Adli, C. Mundt, F. Holsboer, P. Brieger, G. Laux, W. Bender, I. Heuser, J. Zeiler, W. Gaebel, M. Jager, V. Henkel, and H.J. Moller The controversial link between antidepressants and suicidality risks in adults: data from a naturalistic study on a large sample of in-patients with a major depressive episode Int. J. Neuropsychopharmacol. 12 2009 181 189
37. F. Seemuller, R. Schennach-Wolff, M. Obermeier, V. Henkel, H.J. Moller, and M. Riedel Does early improvement in major depression protect against treatment emergent suicidal ideation? J Affect Disord 124 2010 183 186
38. F. Seemuller, M. Riedel, M. Obermeier, M. Bauer, M. Adli, K. Kronmuller, F. Holsboer, P. Brieger, G. Laux, W. Bender, I. Heuser, J. Zeiler, W. Gaebel, E. Dichgans, R. Bottlander, R. Musil, and H.J. Moller Outcomes of 1014 naturalistically treated inpatients with major depressive episode Eur. Neuropsychopharmacol. 20 2010 346 355
39. F. Seemuller, M. Riedel, M. Obermeier, R. Schennach-Wolff, I. Spellmann, S. Meyer, M. Bauer, M. Adli, K. Kronmuller, M. Ising, P. Brieger, G. Laux, W. Bender, I. Heuser, J. Zeiler, W. Gaebel, and H.J. Moller The validity of self-rated psychotic symptoms in depressed inpatients Eur. Psychiatry 2011 doi:10.1016/j.eurpsy.2011.01.004
40. A. Serretti, P. Olgiati, M.N. Liebman, H. Hu, Y. Zhang, R. Zanardi, C. Colombo, and E. Smeraldi Clinical prediction of antidepressant response in mood disorders: linear multivariate vs. neural network models Psychiatry Res. 152 2007 223 231 (Pubitemid 47212479)
41. G.W. Small, S.H. Hamilton, A. Bystritsky, B.S. Meyers, and C.B. Nemeroff Clinical response predictors in a double-blind, placebo-controlled trial of fluoxetine for geriatric major depression. Fluoxetine Collaborative Study Group Int. Psychogeriatr. 7 Suppl 1995 41 53
42. A. Szegedi, M.J. Muller, I. Anghelescu, C. Klawe, R. Kohnen, and O. Benkert Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression J. Clin. Psychiatry 64 2003 413 420 (Pubitemid 36547285)
43. A. Szegedi, W.T. Jansen, A.P. Van Willigenburg, M.E. Van Der, H.H. Stassen, and M.E. Thase Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients J. Clin. Psychiatry 70 2009 344 353
44. M.H. Trivedi, A.J. Rush, S.R. Wisniewski, A.A. Nierenberg, D. Warden, L. Ritz, G. Norquist, R.H. Howland, B. Lebowitz, P.J. Mcgrath, K. Shores-Wilson, M.M. Biggs, G.K. Balasubramani, and M. Fava Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice Am. J. Psychiatry 163 2006 28 40 (Pubitemid 43050100)
45. H.U. Wittchen, U. Wunderlich, S. Gruschwitz, and M. Zaudig Strukturiertes Klinisches Interview f•r DSM-IV 1997 Hogrefe G"ttingen
46. J.R. Wittenborn, N. Kiremitci, and E.S. Weber The choice of alternative antidepressants J. Nerv. Ment. Dis. 156 1973 97 108
47. World Health, O., 1992. The ICD-10 Classification of Mental and behavioural Disorders. Clinical Descriptions and Diagnostic Guidelines. WHO, Geneva.
48. M. Zimmerman, J.I. Mattia, and M.A. Posternak Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice? Am. J. Psychiatry 159 2002 469 473 (Pubitemid 34184745)
49. G.S. Zubenko, B.H. Mulsant, A.H. Rifai, R.A. Sweet, R.E. Pasternak, L.J. Marino JR., and X.M. Tu Impact of acute psychiatric inpatient treatment on major depression in late life and prediction of response Am. J. Psychiatry 151 1994 987 994 (Pubitemid 24208632)